Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). [PDF]
In accordance with Article 6 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive ...
Almeida, A +10 more
core
AB-PINACA. Critical Review Report [PDF]
AB-PINACA (N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide), originally developed by Pfizer Inc. as a synthetic cannabinoid receptor agonist (SCRA), has been encountered outside medical settings as a synthetic constituent and
Brandt, SD
core
Fluoração de 2H-Indazoles [PDF]
openaire +1 more source
Extracting Mechanistic Information from an Open Data Set for a Pharma-Relevant Suzuki-Miyaura Cross-Coupling Reaction. [PDF]
Franklin BA +9 more
europepmc +1 more source
Expression of cyclic nucleotide-gated cation channels in non-sensory tissues and cells [PDF]
Biel, Martin +3 more
core +1 more source
Rh(III)-Catalyzed Regioselective [4 + 2] Annulation of 2-Benzyl-2H-indazole-6-carboxylic Acids with Ynamides to Access Indazole-Fused Pyrans. [PDF]
Hsieh HS +4 more
europepmc +1 more source
Lanthanide complexes with potential temperature-dependent luminescence aplications [PDF]
Kaczmarek, Anna +3 more
core +1 more source
Regioselective Syntheses of Bis(indazolyl)methane Isomers: Controlling Kinetics and Thermodynamics via Tunable Non-Innocent Amines. [PDF]
Álvarez-Sánchez M +6 more
europepmc +1 more source
Lonidamine-1,3,4-oxadiazole derivatives with antiproliferative effects on HCT116 colon cancer cell lines: biological evaluation, ADMET, and computational studies. [PDF]
Bhat RM +6 more
europepmc +1 more source
Design, synthesis, and characterization of novel 5-ethylsulfonyl-indazole-3-carboxamides as dual VEGFR-2 and EGFR inhibitors: apoptotic antiproliferative and immunomodulatory evaluations. [PDF]
Al-Wahaibi LH +5 more
europepmc +1 more source

